Overview

HDDO-1614 Intervention Trial

Status:
Completed
Trial end date:
2017-08-14
Target enrollment:
Participant gender:
Summary
Randomized, Open-label, Single-dose, 3-period, 6-sequence, 3-way crossover Study
Phase:
Phase 1
Details
Lead Sponsor:
Hyundai Pharmaceutical Co., LTD.
Treatments:
Bazedoxifene
Cholecalciferol